z-logo
open-access-imgOpen Access
Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
Author(s) -
Silvio E. Inzucchi,
Mikhail Kosiborod,
David Fitchett,
Christoph Wanner,
Uwe Hehnke,
Stefan Kaspers,
Jyothis T. George,
Bernard Zinman
Publication year - 2018
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.118.035759
Subject(s) - medicine , empagliflozin , glycemic , diabetes mellitus , type 2 diabetes , cardiology , intensive care medicine , insulin , endocrinology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom